Seroprevalence of SARS-CoV-2 antibodies among Japanese healthcare workers from 2020 to 2022 as assayed by two commercial kits

Abstract Antibody tests are used as surveillance tools for informing health policy making. However, results may vary by type of antibody assay and timing of sample collection following infection. Long-term longitudinal cohort studies on antibody assay seropositivity have remained limited, especially...

Full description

Bibliographic Details
Main Authors: Yan Yan, Kaori Saito, Toshio Naito, Kanami Ito, Shuko Nojiri, Yuki Horiuchi, Gautam A. Deshpande, Hirohide Yokokawa, Yoko Tabe
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-53656-2